News Releases

LAVA Therapeutics Appoints Dr. Kapil Dhingra as Chairman of the Board of Directors in Advance of Lead Program Entering the Clinic
Utrecht, The Netherlands and Philadelphia, USA – February 22, 2021 – LAVA Therapeutics B.V., an early clinical-stage biotechnology company focused on applying its expertise in bispecific gamma-delta T cell engagers to transform cancer therapy, today announced the appointment of Dr.
LAVA Therapeutics to Present Corporate Overview at 39th Annual J.P. Morgan Healthcare Conference
Utrecht, The Netherlands and Philadelphia, USA  – January 5, 2021 – LAVA Therapeutics B.V., a biotechnology company focused on applying its expertise in gamma-delta T-cell engagers to transform cancer therapy, today announced that Stephen Hurly, chief executive officer, will present a corporate